CST3 and peripheral arterial disease: In addition to demographics, further adjusting for the presence of cardiometabolic diseases (including Year 2 cardiovascular disease, hypertension, diabetes, and Year 1 peripheral artery disease) and poorer renal function (cystatin C and creatinine) each attenuated half of the cross-sectional metabolite associations by >35%.